Credit Suisse’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,489
Closed -$440K 3263
2023
Q1
$440K Buy
2,489
+71
+3% +$12.6K ﹤0.01% 2802
2022
Q4
$935K Buy
2,418
+1,087
+82% +$420K ﹤0.01% 2370
2022
Q3
$448K Buy
1,331
+8
+0.6% +$2.69K ﹤0.01% 2835
2022
Q2
$435K Sell
1,323
-40
-3% -$13.2K ﹤0.01% 2914
2022
Q1
$596K Sell
1,363
-15
-1% -$6.56K ﹤0.01% 2856
2021
Q4
$605K Buy
1,378
+131
+11% +$57.5K ﹤0.01% 2898
2021
Q3
$694K Sell
1,247
-121
-9% -$67.3K ﹤0.01% 2804
2021
Q2
$702K Buy
1,368
+238
+21% +$122K ﹤0.01% 2831
2021
Q1
$882K Sell
1,130
-256
-18% -$200K ﹤0.01% 2649
2020
Q4
$755K Buy
1,386
+444
+47% +$242K ﹤0.01% 2750
2020
Q3
$431K Sell
942
-90
-9% -$41.2K ﹤0.01% 2745
2020
Q2
$635K Buy
1,032
+382
+59% +$235K ﹤0.01% 2567
2020
Q1
$309K Sell
650
-97
-13% -$46.1K ﹤0.01% 2809
2019
Q4
$433K Buy
747
+7
+0.9% +$4.06K ﹤0.01% 3000
2019
Q3
$487K Buy
740
+212
+40% +$140K ﹤0.01% 2817
2019
Q2
$408K Sell
528
-112
-18% -$86.5K ﹤0.01% 2895
2019
Q1
$453K Sell
640
-94
-13% -$66.5K ﹤0.01% 2823
2018
Q4
$343K Buy
734
+231
+46% +$108K ﹤0.01% 2933
2018
Q3
$434K Sell
503
-172
-25% -$148K ﹤0.01% 2910
2018
Q2
$466K Sell
675
-170
-20% -$117K ﹤0.01% 3005
2018
Q1
$377K Sell
845
-887
-51% -$396K ﹤0.01% 3071
2017
Q4
$763K Buy
1,732
+341
+25% +$150K ﹤0.01% 2710
2017
Q3
$687K Sell
1,391
-1,116
-45% -$551K ﹤0.01% 2889
2017
Q2
$1.39M Buy
+2,507
New +$1.39M ﹤0.01% 2132
2017
Q1
Sell
-435
Closed -$145K 3640
2016
Q4
$145K Sell
435
-23
-5% -$7.67K ﹤0.01% 3525
2016
Q3
$138K Sell
458
-268
-37% -$80.8K ﹤0.01% 3538
2016
Q2
$125K Buy
726
+201
+38% +$34.6K ﹤0.01% 3710
2016
Q1
$118K Buy
+525
New +$118K ﹤0.01% 3500
2015
Q4
Sell
-278
Closed -$143K 4082
2015
Q3
$143K Sell
278
-483
-63% -$248K ﹤0.01% 3817
2015
Q2
$333K Buy
761
+78
+11% +$34.1K ﹤0.01% 3687
2015
Q1
$247K Buy
+683
New +$247K ﹤0.01% 3697
2014
Q4
Sell
-552
Closed -$166K 4288
2014
Q3
$166K Buy
+552
New +$166K ﹤0.01% 3796